According to the Regulations on RUSNANOPRIZE, following management and awarding bodies of the Prize are established:
RUSNANOPRIZE International Award Committee is formed for the term of one year in order to hold the Prize competition and select the Prize laureate.
The Prize Committee has up to thirty members, who represent the international scientific community and innovative business, including one Committee Chairman to be elected for the term of one year by secret ballot of the Prize Committee members. The Prize Committee Chairman supervises activities of the Prize Committee.
Members of the Prize Committee are representatives of the scientific community and innovative business, who are generally acknowledged to have achieved outstanding results in the field that the Prize is awarded in the current year. At least one half of the Prize Committee members must be foreign nationals.
The functions of the Prize Committee are as follows:
- Approving the form of application / nomination which must be filed by Prize applicants
- Defining the structure and approving the members of the Expert Group
- Deciding to award the Prize and selection of winners for the year
- Deciding not to award the Prize for the current year
Chief Medical Officer and Head of Medical Affairs and Pharmacovigilance for Pharmaceuticals Division, Bayer HealthCare AG
Distinguished Professor of Pharmaceutics, School of Pharmacy, Connecticut University
Robert M. Nerem
Institute Professor and Parker H. Petit Distinguished Chair Emeritus, Woodruff School of Mechanical Engineering and Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology
Evgeny D. Sverdlov
Advisor Molecular Genetics Institute, Russian Academy of Sciences
Acting Dean, The Pirogov Russian National Research Medical University (RNRMU), Ministry of Health Care of the Russian Federation
Chief Scientist at “R&D Center for biomedical chemistry named after V.N. Orekhovich”, Russian Academy of Medical Sciences
Igor R. Efimov
Alisann & Terry Collins Professor and Chairman, Department of Biomedical Engineering George Washington University
Director, “Federal Epidemiology and Microbiology Research and Development Center of a Distinguished Academician N. F. Gamalei” of the Ministry of Health Care of the Russian Federation
Kam W Leong
Professor of Biomedical Engineering, Columbia University
Academician, Director of the Bioengineering Center, Russian Academy of Sciences
Professor of Bioengineering and Chemical Engineering, University of Washington
John C. Reed
Head of Pharma Research & Early Development (pRED), Roche
Chairman of the Board, Khimrar
Vladimir P. Torchilin
PhD, DSc, University Distinguished Professor; Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University
Ph.D. Chief Scientific Officer, External R&D Innovation (ERDI), Senior Vice President, Pfizer Worldwide R&D, Pfizer
Professor Emeritus at University College London, PhD, DSc , Founder, Science Adviser, Xenetic Biosciences Inc
Robert S. Langer
David H. Koch Institute Professor, Massachusetts Institute of Technology - MIT
Chairman of the Executive Board, RUSNANO Corporation
Jackie Y. Ying
Executive Director of the Institute of Bioengineering and Nanotechnology of Singapore's Agency for Science, Technology and Research (A*STAR)
The Prize Directorate is formed in order to coordinate preparation and support of the Prize competition and awarding of the Prize.
The competencies of the Prize Directorate include:
- working with other bodies to organize the competition and awards
- hosting, information support, and promotion of the Prize
- arranging and conducting the Prize award ceremony
- representing the interests of the Prize competition in dealings with Russian and international public, government, scientific organisations, and private individuals.
The Prize Directorate is not obliged to explain its reasons for rejecting applications.